QWP
AZN icon

Quotient Wealth Partners’s AstraZeneca AZN Stock Holding History

Quotient Wealth Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$330K Buy
1,671
+169
+11% +$32.6K 0.01% 265
2025
Q4 		$276K Sell
1,502
-64
-4% -$11.2K 0.01% 290
2025
Q3 		$240K Sell
1,566
-242
-13% -$36.6K 0.01% 317
2025
Q2 		$253K Sell
1,808
-268
-13% -$37.6K 0.01% 302
2025
Q1 		$305K Sell
2,076
-436
-17% -$63.1K 0.01% 256
2024
Q4 		$329K Sell
2,512
-382
-13% -$53.5K 0.01% 231
2024
Q3 		$451K Buy
2,894
+113
+4% +$18.2K 0.01% 186
2024
Q2 		$434K Buy
2,781
+1,123
+68% +$169K 0.02% 188
2024
Q1 		$225K Buy
+1,658
New +$220K 0.01% 282

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Quotient Wealth Partners's AZN Position: Q1 2026 in Review

Quotient Wealth Partners increased its AstraZeneca (AZN) stake by 11% in Q1 2026, buying an estimated $32.6K and bringing the position to 1,671 shares worth $330K. The position accounts for 0.01% of the portfolio, ranked #265.

Quotient Wealth Partners first reported a position in AZN in Q1 2024 and has held it in 9 quarters since. The position peaked at $451K in Q3 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Quotient Wealth Partners held 1,671 shares of AstraZeneca worth $330K as of Q1 2026.
  • Quotient Wealth Partners bought 169 AstraZeneca shares in Q1 2026, an estimated $32.6K.
  • AstraZeneca made up 0.01% of Quotient Wealth Partners's portfolio in Q1 2026, its #265 holding.
  • Quotient Wealth Partners first reported a position in AstraZeneca in Q1 2024 and has held it in 9 quarters since.
  • Quotient Wealth Partners's AstraZeneca position peaked at $451K in Q3 2024.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Quotient Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.